Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-07 Purchase |
2024-02-09 5:51 pm |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
100,000 | $1.35 | $135,000 | 103,334 (Indirect Direct) |
View |
| 2024-02-07 Purchase |
2024-02-09 5:50 pm |
Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director |
130,000 | $1.35 | $175,500 | 130,000 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-18 6:54 pm |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
6,201 | $1.5206 | $9,429 | 47,674 (Direct) |
View |
| 2023-06-07 Purchase |
2023-06-09 4:26 pm |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer |
100,000 | $1.4549 | $145,490 | 100,000 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 6:02 pm |
Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer |
7,299 | $0.7816 | $5,705 | 117,435 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 6:02 pm |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer |
13,360 | $0.7816 | $10,442 | 265,891 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 6:01 pm |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
41,239 | $0.7816 | $32,232 | 692,141 (Direct) |
View |
| 2022-09-19 Sale |
2022-09-21 8:01 pm |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
4,272 | $1.0697 | $4,570 | 39,061 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-17 Option Award |
2024-06-20 4:48 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:47 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:46 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:45 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:44 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
10,520 | $0 | 10,520 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:43 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director |
13,820 | $0 | 13,820 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 4:43 pm |
N/A 2034-06-16 |
Adverum Biotechnologies Inc. | ADVM | Kiss Szilard Director |
21,040 | $0 | 21,040 (Direct) |
View |
Ownership |
2024-06-20 4:42 pm |
N/A 2026-11-01 |
Adverum Biotechnologies Inc. | ADVM | Kiss Szilard Director |
0 | $0 | 20,750 (Direct) |
View |
| 2023-10-03 Option Award |
2024-03-12 7:07 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER |
85,000 | $0 | 85,000 (Direct) |
View |
| 2023-10-03 Option Award |
2024-03-12 7:06 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
130,000 | $0 | 130,000 (Direct) |
View |
| 2023-10-03 Option Award |
2024-03-12 7:05 pm |
N/A 2032-03-07 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR |
315,000 | $0 | 315,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:33 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER |
400,000 | $0 | 400,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:31 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR |
1,104,200 | $0 | 1,104,200 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:29 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER |
350,000 | $0 | 350,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 4:27 pm |
N/A 2034-02-11 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-11-03 Option Award |
2023-11-06 7:54 pm |
N/A 2033-11-02 |
Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director |
80,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2023-11-06 7:52 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director |
0 | $0 | 0 (Direct) |
View |
| 2023-08-03 Option Award |
2023-09-05 4:14 pm |
N/A 2033-08-02 |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer |
850,000 | $0 | 850,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:19 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:17 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:15 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:13 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:10 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:05 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:03 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Hong Soo Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:02 pm |
N/A 2033-06-08 |
Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director |
52,500 | $0 | 92,500 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:24 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Riley Brigit Chief Scientific Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:24 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh Chief Development Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:23 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Beckman Richard Chief Medical Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:22 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Soparkar Peter Chief Operating Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-03 5:21 pm |
N/A 2033-02-28 |
Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, President and Director |
930,000 | $0 | 930,000 (Direct) |
View |
Ownership |
2022-12-15 5:27 pm |
N/A N/A |
Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |